Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund II - Biotechnology Sub-Fund

+ Add to Watchlist

CARBIOA:LX

37.12 EUR

As of 00:00:00 ET on 03/27/2015.

Snapshot for Carnegie Fund II - Biotechnology Sub-Fund (CARBIOA)

Year To Date: +18.56% 3-Month: +23.86% 3-Year: +45.42% 52-Week Range: 21.19 - 39.58
1-Month: +3.20% 1-Year: +48.36% 5-Year: +35.95% Beta vs CXBT: -

Mutual Fund Chart for CARBIOA

No chart data available.
  • CARBIOA:LX 37.12
  • 1M
  • 1Y
Interactive CARBIOA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CARBIOA

Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.

Inception Date: 10-10-2000 Telephone: 352-40-40-30-1
Managers: ULF ARVIDSSON
Web Site: www.carnegieam.com

Fundamentals for CARBIOA

NAV (on 2015-03-27) 37.12
Assets (M) (on 2015-02-27) 34.66
Fund Leveraged N
Minimum Investment 15,000.00
Minimum Subsequent Investment -

Dividends for CARBIOA

No dividends reported

Fees & Expenses for CARBIOA

Front Load -
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.10

Top Fund Holdings for CARBIOA

Filing Date: 02/27/2015
Name Position Value % of Total
Celgene Corp 26,400 2,896,450 8.357%
Biogen Inc 7,000 2,551,903 7.363%
Gilead Sciences Inc 27,500 2,543,566 7.339%
Vertex Pharmaceuticals Inc 21,400 2,293,376 6.617%
Alexion Pharmaceuticals Inc 12,100 1,965,412 5.671%
Cempra Inc 56,000 1,644,468 4.745%
Medivation Inc 15,000 1,586,193 4.576%
BioMarin Pharmaceutical Inc 15,800 1,523,803 4.396%
Salix Pharmaceuticals Ltd 10,700 1,500,199 4.328%
Auspex Pharmaceuticals Inc 24,000 1,475,067 4.256%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil